Mahady, Redmond move up at Wyeth

Share this article:
Wyeth named Joe Mahady president, Wyeth Pharmaceuticals and SVP, Wyeth.

In February, Mahady was named president, global business for the company's pharmaceuticals division, with responsibility for all worldwide commercial business. Prior to that, he was president, Americas and global business, in which role he presided over steep cuts in the company's US primary care sales force, supplemented by the hiring of flex-time reps. He joined the company in 1979 as a pharmacist with its regulatory affairs division.

Also moving up are Wyeth BioPharma head Cavan Redmond, who becomes president, Wyeth Consumer Healthcare, and Richard DeLuca, who becomes president, Fort Dodge Animal Health.

They will assume their new roles Jan. 1, the day Bernard Poussot takes the reins from CEO Bob Essner, who is retiring.

Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.